Tech Company Financing Transactions
QuVa Pharma Funding Round
QuVa Pharma closed a $35 million investment round on 2/2/2018. Backers included Bain Capital Private Equity, Farnam Street Financial and Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
2/2/2018
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$35,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The new capital will help fund several of the company's strategic expansion priorities, to assist in meeting the significant demand it is experiencing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Sugar Creek Center Blvd. 250
Sugar Land, TX 77478
USA
Sugar Land, TX 77478
USA
Phone
Website
Email Address
Overview
QuVa Pharma will be the industry's leading 503B platform and the partner of choice for compliance-oriented healthcare facilities looking to ensure quality, safe and consistent supply of medications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stuart Hinchen
Chief Financial Officer
Brett Coverdale
Chief Operating Officer
Scott Aladeen
Vice President
Varsha Gaitonde
Vice President
Donna Kohut
Vice President
Travis Leeah
VP - Bus. Development
Peter Jenkins
VP - Human Resources
Tracey Gibbs
VP - Marketing
Michael Scouvart
VP - Operations
Michael Rutkowski
VP - Regulatory Affairs
David Short
VP - Sales
Ray Dixon
Browse more venture capital transactions:
Prev: 2/1/2018: WePower venture capital transaction
Next: 2/2/2018: Partner Therapeutics venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs